Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center recalls PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 m
Recalled October 30, 2019 · FDA recall D-0149-2020 · Nephron Pharmaceuticals Corporation
Hazard
GMP Deviations: potential glass contamination · FDA Class II
Units
615 bags
Sold at
Nationwide.
Description
GMP Deviations: potential glass contamination
Product
PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 mg)/200 mL, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-526-20
Manufacturer(s)
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →